Amdocs Limited (NASDAQ:DOX – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the five research firms that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $101.20.
Several analysts have recently issued reports on the company. StockNews.com downgraded Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, January 14th. Barclays dropped their price target on Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a report on Thursday, November 14th. Finally, Oppenheimer increased their price objective on Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th.
Get Our Latest Stock Analysis on DOX
Amdocs Trading Down 0.9 %
Amdocs Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Tuesday, December 31st were given a $0.479 dividend. The ex-dividend date of this dividend was Tuesday, December 31st. This represents a $1.92 annualized dividend and a yield of 2.19%. Amdocs’s dividend payout ratio (DPR) is presently 45.28%.
Institutional Investors Weigh In On Amdocs
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Redmond Asset Management LLC purchased a new position in shares of Amdocs in the 4th quarter worth $887,000. Dividend Assets Capital LLC lifted its holdings in Amdocs by 1.0% during the 4th quarter. Dividend Assets Capital LLC now owns 70,725 shares of the technology company’s stock valued at $6,022,000 after buying an additional 721 shares in the last quarter. Paradigm Asset Management Co. LLC bought a new stake in shares of Amdocs in the 4th quarter valued at about $1,141,000. Handelsbanken Fonder AB raised its stake in shares of Amdocs by 6.2% during the 4th quarter. Handelsbanken Fonder AB now owns 50,115 shares of the technology company’s stock worth $4,267,000 after acquiring an additional 2,910 shares in the last quarter. Finally, Global Retirement Partners LLC raised its stake in shares of Amdocs by 45.6% during the 4th quarter. Global Retirement Partners LLC now owns 559 shares of the technology company’s stock worth $48,000 after acquiring an additional 175 shares in the last quarter. Hedge funds and other institutional investors own 92.02% of the company’s stock.
About Amdocs
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Articles
- Five stocks we like better than Amdocs
- What is the MACD Indicator and How to Use it in Your Trading
- How to Invest in Small Cap Stocks
- What is the Euro STOXX 50 Index?
- These Are the Dividend Stocks Insiders Bought in January
- The How And Why of Investing in Oil Stocks
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.